Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 1:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 3,875 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: fast Clear all

Conditions: HIV Infections
Interventions: TERA Intervention (TERA), Standard of Care (SOC); Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 13 Years to 24 Years
Enrollment: 89 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 8
States / cities: Aurora, Colorado • Fort Lauderdale, Florida • Jacksonville, Florida + 5 more

Conditions: General Surgery
Interventions: 25° head-up position, 55° head-up position; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Cellulite
Interventions: Soliton's Rapid Acoustic Pulse (RAP); Device
Lead sponsor: Soliton; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 67 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 4
States / cities: Scottsdale, Arizona • Chicago, Illinois • Chevy Chase, Maryland + 1 more

Conditions: Cancer, Pediatric Cancer
Interventions: Questionnaire, Physical Exam; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 30 Days to 30 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: Aurora, Colorado • Portland, Oregon

Conditions: Herpes Simplex Virus 2
Interventions: Not listed
Lead sponsor: Focus Diagnostics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Burbank, California

Conditions: Progressive Multiple Sclerosis
Interventions: G-EO System (Reha Technology AG: Olten, Switzerland), Conventional Physical Therapy; Device · Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Urea Cycle Disorders
Interventions: HPN-100, NaPBA; Drug
Lead sponsor: Amgen; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 7
States / cities: Los Angeles, California • Washington D.C., District of Columbia • New York, New York + 4 more

Conditions: Healthy
Interventions: Reformulated OXY (Totowa) (oxycodone HCl), Reformulated OXY (Wilson) (oxycodone HCl); Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Pulmonary Disease, Chronic Obstructive, Respiratory Insufficiency
Interventions: Vapotherm High Flow Therapy, Non-invasive positive pressure ventilation; Device
Lead sponsor: Vapotherm, Inc.; Industry
Eligibility: 50 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Chronic Nociceptive Pain, Neuropathic Pain, Non-cancer Pain
Interventions: Oxymorphone ER; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Immune Surveillance
Interventions: Placebo, Nutraceutical blend; Dietary Supplement
Lead sponsor: Natural Immune Systems Inc; Other
Eligibility: 18 Years to 75 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Klamath Falls, Oregon

Conditions: Cutaneous Abscess
Interventions: Xpert MRSA/SA SSTI, Standard culture; Device · Diagnostic Test
Lead sponsor: George Washington University; Other
Eligibility: 18 Years and older
Enrollment: 252 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Healthy
Interventions: Azithromycin, Zithromax®; Other · Drug
Lead sponsor: Teva Pharmaceuticals USA; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Obesity, Healthy Volunteers, Overweight
Interventions: [c11] raclopride, [18F]fallypride; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Bleeding, Cramping, Pregnancy With IUD in Place, IUD Expulsion, IUD Removal
Interventions: Text message; Other
Lead sponsor: Columbia University; Other
Eligibility: Female only
Enrollment: 230 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Volunteers
Interventions: AZD9291; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Overland Park, Kansas

Conditions: Gynecologic Cancer
Interventions: Gadobutrol, MRI; Drug · Diagnostic Test
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 3
States / cities: Montvale, New Jersey • New York, New York • Uniondale, New York

Conditions: Walking, Difficulty, Mobility Limitation
Interventions: FAST (Functional Activity Strength Training), Band Together, Behavioral Change Technique; Behavioral
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 702 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Healthy
Interventions: Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets; Drug
Lead sponsor: Ranbaxy Laboratories Limited; Industry
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Spinal Cord Injury
Interventions: ACCESS, IPS; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 2
States / cities: Tampa, Florida • Richmond, Virginia

Conditions: Bile Duct Cancer, Intrahepatic Cholangiocarcinoma, Cholangiocarcinoma of the Extrahepatic Bile Duct
Interventions: Cabozantinib; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Suicidal Ideation
Interventions: Ketamine, Midazolam; Drug
Lead sponsor: James Murrough; Other
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Healthy Volunteers
Interventions: ZM-H1505R; Drug
Lead sponsor: Shanghai Zhimeng Biopharma, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Secaucus, New Jersey

Conditions: Healthy Volunteer
Interventions: ANG-3777 (Therapeutic Dose), ANG-3777 (Supra-therapeutic Dose), Placebo, Moxifloxacin Hydrochloride; Drug
Lead sponsor: Angion Biomedica Corp; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Miami, Florida

Search by objective public record fields.

Triggered Escalating Real-time Adherence (TERA) Intervention

Evaluation of Apnea Tolerance in Bariatric Patients Following Rapid-sequence Induction of Anesthesia

Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite

Integrative Health Interventions in Symptom Management of Pediatric Patients

HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population

G-EO Gait Rehabilitation Training in Progressive Multiple Sclerosis

Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders

To Determine the Fasting Bioequivalence of Reformulated OXY Tablets Manufactured at Two Different Facilities

High Flow Therapy (HFT) to Treat Respiratory Insufficiency in Chronic Obstructive Pulmonary Disease (COPD)

A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone

Clinical Trial on Rapid Immune Modulating Effects

Antimicrobial Stewardship Through MRSA Diagnosis in Emergency Department (ED) Patients With Abscesses

A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions

Brain Dopamine Function in Human Obesity

Quick Start Insertion of Mirena and ParaGard

To Determine the Relative Bioavailability of Different Formulations of AZD9291 and the Effect of Food.

Novel Imaging Technique to Assess Gynecologic Cancer

Testing Interventions for Mobility Through Exercise (TIME)

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

Customized Employment for Veterans With Spinal Cord Injury

Cabozantinib (XL-184) Monotherapy for Advanced Cholangiocarcinoma

Ketamine For Suicidal Ideation

A Study of Orally Administered ZM-H1505R to Evaluate Safety, Tolerability and Pharmacokinetics After Single and Multiple Ascending Doses in Healthy Participants

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval